For those with deeper tones, wearing a tinted mineral sunscreen with iron oxides is important to protect against both ultraviolet (UV) and light exposure, added dermatologist Toral Vaidya, MD
Storage Mastery: Making Your GLP-1 Last Want to maximize your medications lifespan
Theres no prescription, lab work, or medical oversight
Phase III results for retatrutide are set to be released later in 2025 and in early 2026, but an earlier phase II trial recorded between a 7.2% and 17.5% reduction in body weight after 24 weeks, depending on the dose (7.2% on 1mg, 17.5% on 12mg), and up to a 24.2% reduction in body weight after 48 weeks for those on 12mg (-8.7% change for those on 1mg) 8
Your injection volumes are larger
The results of this study do not suggest GLP-1 receptor agonist medications should supplant evidence-based treatments for binge eating disorder, including cognitive behavioral therapy, she said, noting that this is currently the primary treatment method